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Supplemental Table S1: Search strategy   
 
Databases Searched Search Terms  
Medline, Pubmed, 
Cochrane Central 
Register of Controlled 
Trials (CENTRAL), 
Embase, CINAHL 
(Gestational diabetes mellitus OR GDM OR gestational diabetes OR diabetes, 
pregnancy induced OR diabetes mellitus, gestational OR pregnancy, glucose 
intolerance OR pregnancy, hyperglycaemia OR pregnancy glycaemic index OR 
Pregnancy-Induced Diabetes OR Diabetes, Gestational) AND (diet* OR nutrition* 
OR food intake OR dietary intake OR food consumption OR calorie intake OR 
energy intake OR kilojoule intake OR calorie restriction OR diet* therapy OR 
vitamin OR nutrition* therapy OR dietary carbohydrates OR dietary fibre OR 
beverage OR nutrient OR macronutrient OR micronutrient OR dietary intervention 
OR diet supplement OR (Diet, Sodium-Restricted/ or Diet, Vegetarian/ or Diet, 
Mediterranean/ or Diet, Carbohydrate-Restricted/ or Diet, Macrobiotic/ or diet or 
Diet/ or Diet, High-Fat/ or Diet, Diabetic/ or Diet Records/ or Ketogenic Diet/ or 
Diet, Cariogenic/ or Diet, Vegan/ or Diet, Protein-Restricted/ or Diet, Fat-Restricted/ 
or Diet, Reducing/ or Diet Therapy/ or Diet, Gluten-Free)) AND (randomized 
controlled trial OR controlled clinical trial OR randomized OR placebo OR drug 
therapy OR randomly OR trial OR groups)  
Web of Science, Scopus   TI= TS=(Gestational diabetes mellitus or GDM or gestational diabetes or diabetes, 
pregnancy induced or diabetes mellitus or gestational or pregnancy, glucose 
intolerance or pregnancy, hyperglycaemia or pregnancy glycaemic index or 
Pregnancy-Induced Diabetes) AND 
TI= TS= (diet* or nutrition* or food intake or dietary intake or food consumption or 
calorie intake or energy intake or kilojoule intake or calorie restriction or diet* 
therapy or vitamin or nutrition* therapy or dietary carbohydrates or dietary fibre or 
dietary fiber or beverage or nutrient or macronutrient or micronutrient or dietary 
intervention or diet supplement or Gluten-Free) 
TI= TS=(randomized controlled trial or controlled clinical trial or randomized or 
randomly or trial or  groups) 
Applied Social Sciences 
Index & Abstracts 
(ASSIA) ProQuest 
ab(Gestational diabetes mellitus OR gestational diabetes OR diabetes, pregnancy 
induced OR pregnancy, glucose intolerance OR pregnancy, hyperglycaemia OR 
pregnancy glycaemic index OR Pregnancy-Induced Diabetes) AND ab(diet* OR 
nutrition* OR food intake OR dietary intake OR food consumption OR calorie intake 
OR energy intake OR kilojoule intake OR calorie restriction OR diet* therapy OR 
vitamin OR nutrition* therapy OR dietary carbohydrates OR dietary fibre OR dietary 
fiber OR beverage OR nutrient OR macronutrient OR micronutrient OR dietary 
intervention OR diet supplement OR Gluten-Free) AND (randomized controlled trial 
OR controlled clinical trial OR randomized OR randomly OR trial OR groups) 
ProQuest Dissertations 
& Theses, NICE 
evidence search, 
ISRCTN, 
ClinicalTrials.gov 
Diet and gestational diabetes 
UK Clinical Trials 
Gateway 
Diet or Nutrition and gestational diabetes 
 
 
 
Supplementary Table S2: Results from pooled analysis of secondary maternal outcomes for the 
main analysis  
 
Outcome  Diet Subgroup (to 
add references) 
No. of 
Studies 
No. of 
Women 
Effect estimate I2 (%) 
    Mean [95% CI]  
Weight gain over 
pregnancy (kg) 
 
9 539 -0.64 [-1.66, 0.38] 0 
 Low GI 2 170 -0.74 [-2.10, 0.61] 0 
 DASH 3 119 0.08 [-3.62, 3.77] 0 
 Energy restriction 1 124 1.88 [-1.95, 5.71] - 
 Fat modification 1 84 -2.00 [-4.33, 0.33] - 
 Ethnic diet 1 20 -2.20 [-7.24, 2.84] - 
 Fiber 1 22 2.40 [-2.20, 7.00] - 
Weight gain from study 
inclusion (kg)  11 717 -0.21 [-0.49, 0.08] 2 
 Low GI 1 63 -0.05 [-1.13, 1.03] - 
 DASH 3 119 -0.36 [-1.23, 0.51] 0 
 Low carbohydrate 2 157 -0.89 [-1.58, -0.20] 0 
 Energy restriction 1 124 -0.67 [-1.72, 0.38] - 
 Fat modification 1 25 0.20 [-1.47, 1.87] - 
 Soya protein 2 130 -0.02 [-0.74, 0.71] 65 
 Behavior 1 99 -0.30 [-1.38, 0.78] - 
    Relative Risk [95% CI]  
Preeclampsia/ eclampsia  All 5 368 1.00 [0.56, 1.78] 0 
 Low GI 1 81 0.33 [0.01, 7.76] - 
 DASH 2 98 1.00 [0.22, 4.64] 0 
 Energy restriction 1 121 0.99 [0.51, 1.93] - 
 Soya protein 1 68 2.00 [0.19, 21.03] - 
Cesarean section  All 13 825 0.89 [0.70, 1.13] 38 
 Low GI 2 145 1.14 [0.52, 2.51] 31 
 DASH 3 119 0.54 [0.40, 0.74] 0 
 Low carbohydrate 3 191 1.34 [0.87, 2.05] 0 
 Energy restriction 1 121 1.18 [0.74, 1.89] - 
 Soya protein 2 130 0.95 [0.58, 1.54] 0 
 Behavior 1 99 0.78 [0.38, 1.62] - 
 Ethnic diet 1 20 1.20 [0.54, 2.67] - 
 
Supplementary Table S3: Results from pooled analysis of secondary neonatal outcomes for the 
main analysis 
 
 
Outcome  Diet Subgroup (to 
add references) 
No. of 
Studies 
No. of 
Women 
Effect estimate  
Relative Risk [95% CI] 
I2 (%) 
Neonatal hypoglycemia as 
defined by the authors   All 3 320 0.77 [0.52, 1.12] 0 
 Low carbohydrate 1 149 0.91 [0.39, 2.12] - 
 Energy restriction 1 109 0.75 [0.48, 1.15] - 
 Soya protein 1 62 0.44 [0.04, 4.60]  
Preterm birth  All 5 430 0.77 [0.34, 1.73] 0 
 Low GI 2 179 0.75 [0.27, 2.06] 0 
 Fat modification 1 84 Not estimable - 
 Soya protein 1 68 2.00 [0.19, 21.03] - 
 Behavior 1 99 0.51 [0.10, 2.66] - 
Neonatal intensive care 
unit All 2 167 0.53 [0.06, 5.13] 79 
 Soya protein 1 68 0.14 [0.02, 1.10] - 
 Behavior 1 99 1.33 [0.73, 2.44] - 
Small for gestational age All 5 362 0.90 [0.47, 1.71] 0 
 Low GI 3 193 1.63 [0.55, 4.83] 0 
 Low carbohydrate 1 149 0.68 [0.29, 1.56] - 
 Ethnic diet 1 20 0.33 [0.02, 7.32] - 
 
 
Supplemental Table S4: GRADE 
 
The quality of evidence is graded, described and graphically presented in four levels: GRADE± 
1) Very low quality (Ꚛꓳꓳꓳ) which means there is very little confidence in the effect estimate and the 
effect is likely to be substantially different from the estimate of effect; 
 2) Low quality (ꚚꚚꓳꓳ), which means there is limited confidence in the effect estimate and the true 
effect may be substantially different from the estimate of the effect;  
3) Moderate quality (ꚚꚚꚚꓳ), which means, there is moderate confidence in the effect estimate, and the 
he true effect is likely to be close to the estimate of the effect, but there is a possibility that it is 
substantially different;  
4) High quality (ꚚꚚꚚꚚ), which there is high confidence that the true effect lies close to that of the 
estimate of the effect. 
 
 
Outcome Studies 
No. of 
Studies 
No. of 
Women 
GRADE Downgrade Considerations 
Change in fasting 
glucose 
25, 28, 29, 
21, 35, 12, 
24, 27, 34, 
14, 26, 23, 
33 
13 662 Ꚛꓳꓳꓳ Study limitations: High risk of selection, 
performance, detection, attrition and reporting 
bias. 
Inconsistency: Considerable 
Indirectness: population applicability 
Change in 
postprandial 
glucose 
25, 29, 21, 
24, 27, 34, 
14, 23, 33 
9 475 Ꚛꓳꓳꓳ Study limitations: High risk of performance, 
detection, attrition and reporting bias. 
Indirectness: population applicability 
Change in post-
breakfast glucose 
29, 24, 14 3 175 ꚚꚚꓳꓳ Study limitations: High risk of performance and 
detection and reporting bias. 
Imprecision: wide confidence interval and small 
sample size 
Change in post-
lunch glucose 
24,14 2 92 ꚚꚚꓳꓳ Study limitations: High risk of performance and 
detection and reporting bias. 
Imprecision: wide confidence interval and small 
sample size 
Change in post-
dinner glucose 
24,14 2 92 ꚚꚚꓳꓳ Study limitations: High risk of performance and 
detection and reporting bias. 
Imprecision: wide confidence interval and small 
sample size 
Change in 
HOMA-IR 
35, 12, 26, 
23 
4 212 Ꚛꓳꓳꓳ Study limitations: High risk of reporting bias. 
Imprecision: wide confidence interval 
Inconsistency: Considerable 
Change in HbA1c 28, 29, 21, 
27, 14, 23, 
33 
7 407 Ꚛꓳꓳꓳ Study limitations: High risk of performance, 
selection, detection and reporting bias. 
Imprecision: wide confidence interval 
Inconsistency: Considerable 
Medication use 13, 25, 28, 
29, 21, 22, 
35, 30, 31, 
34, 26, 23, 
33, 32 
15 1023 ꚚꚚꓳꓳ Study limitations: High risk of selection, 
performance, attrition and detection bias. 
Indirectness: population applicability 
Birthweight 13, 25, 28, 
29, 21, 22, 
35, 12, 24, 
31, 27, 34, 
14, 26, 33, 
32 
16 841 Ꚛꓳꓳꓳ Study limitations: High risk of selection, 
performance, attrition, detection and reporting 
bias. 
Imprecision: wide confidence interval 
Inconsistency: Considerable 
Indirectes: population applicability 
Large for 
gestational age 
13, 25, 28, 
30, 31, 14, 
23, 33 
8 647 ꚚꚚꓳꓳ Study limitations: High risk of performance, 
attrition, detection and reporting bias. 
Indirectes: population applicability 
Macrosomia 13, 25, 28, 
29, 22, 35, 
24, 30, 31, 
34, 26, 33 
12 834 ꚚꚚꓳꓳ Study limitations: High risk of selection, 
performance, detection and attrition bias. 
Indirectes: population applicability 
 
  
 
 
 
Supplemental Figure S1: PRISMA flow diagram  
 
3660 records identified 
through database search
128 records identified 
through other sources
2269 records after duplicates 
removed 
2269 records screened
126 full-text articles 
assessed for eligibility   
18 studies included in 
quantitative synthesis 
(meta-analysis)
2144 records excluded based on 
title and abstract review  
108 Full-Text Articles Excluded
Inappropriate study design (n=21)
Did not have relevant maternal and 
fetal outcomes (n=11)
Inappropriate population (n=14)
Inappropriate diet intervention or 
control (n=36)
Protocol only (n=5)
Postpartum studies (n=9)
Repeat cohort (n=1)
Conference abstract (n=5)
Unable to translate (n=4)
Unable to obtain full text (n=2)
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S2: Risk of bias summary  
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S3: Risk of bias summary  
 a. Change in fasting glucose    b. Change in post-meal glucose  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c. Change in HOMA-IR      d. Change in HbA1c  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
e. Relative risk of insulin use  
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S4: Funnel plots for maternal glycemic outcomes for main analysis  
 a. Birthweight      b. Large for gestational age  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c. Macrosomia         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S5: Funnel plots for neonatal birthweight outcomes for main analysis 
 a. Change in fasting glucose    b. Change in post-meal glucose  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c. Change in HOMA-IR      d. Change in HbA1c  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
e. Relative risk of insulin use  
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S6: Funnel plots for maternal glycemic outcomes for sensitivity analysis  
 a. Birthweight      b. Large for gestational age  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c. Macrosomia         
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure S7: Funnel plots for neonatal birthweight outcomes for sensitivity 
analysis 
 
